Note 14 - Share-based Compensation (Tables)

9 Months Ended

Sep. 30, 2022

Notes Tables

Share-Based Payment Arrangement, Option, Activity [Table Text Block]

	Nine Months Ended
	September 30, 2022
	Shares			Wtd. Avg. Exercise Price
Outstanding as of beginning of year		624,531		$	2.13
Exercised		(158,075	)		1.94
Forfeited		(10,000	)		1.82
Outstanding as of September 30, 2022		456,456		$	2.20
Stock options exercisable as of September 30, 2022		456,456		$	2.20

Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]

	Nine Months Ended
	September 30, 2022
	Shares			Wtd. Avg. Grant Date Fair Value
Outstanding as of beginning of year		1,212,783		$	37.48
Granted		1,255,449			25.55
Vested		(448,056	)		35.60
Forfeited		(83,922	)		46.29
Non-vested as of September 30, 2022		1,936,254		$	29.79

	Nine Months Ended
	September 30, 2022
	Shares			Wtd. Avg. Grant Date Fair Value
Outstanding as of beginning of year		139,756		$	19.86
Granted		349,568			21.26
Vested		(218,280	)		10.95
Non-vested as of September 30, 2022		271,044		$	30.64

Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2022		2021		2022		2021
Cost of revenue	$	809	$	742	$	2,619	$	1,047
General and administrative costs		3,959		3,015		10,687		5,662
Sales and marketing costs		829		560		2,272		1,012
Research and development costs		702		551		2,093		1,171
Total	$	6,299	$	4,868	$	17,671	$	8,892